540 related articles for article (PubMed ID: 7818713)
1. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
Hussein MM; Mooij JM; Roujouleh H
Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
[No Abstract] [Full Text] [Related]
2. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
Holley JL; Nolan TA; Piraino B
Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
[TBL] [Abstract][Full Text] [Related]
4. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
Caillette A; Barreto S; Gimenez E; Labeeuw M; Zech P
Clin Nephrol; 1993 Sep; 40(3):176-8. PubMed ID: 8403574
[TBL] [Abstract][Full Text] [Related]
5. r-HuEPO treatment of anemia associated with multiple myeloma and ESRD.
Van der Niepen P; Sennesael J; Verbeelen D
Clin Nephrol; 1993 Feb; 39(2):113. PubMed ID: 8448915
[No Abstract] [Full Text] [Related]
6. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
[No Abstract] [Full Text] [Related]
7. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients.
Ruedin P; Pechère Bertschi A; Chapuis B; Benedet P; Leski M
Nephrol Dial Transplant; 1993; 8(4):315-8. PubMed ID: 8390005
[TBL] [Abstract][Full Text] [Related]
8. Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis.
Taylor J; Mactier RA; Stewart WK; Henderson IS
BMJ; 1990 Sep; 301(6750):476-7. PubMed ID: 2207402
[No Abstract] [Full Text] [Related]
9. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
Binkley LS
Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
[No Abstract] [Full Text] [Related]
10. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
[TBL] [Abstract][Full Text] [Related]
11. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
Verbeelen D; Hauglustaine D; Sennesael J
Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
[No Abstract] [Full Text] [Related]
12. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
[TBL] [Abstract][Full Text] [Related]
13. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
Eschbach JW; Haley NR; Adamson JW
Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
[No Abstract] [Full Text] [Related]
14. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
Salim KA; Salim S; Mathew T
J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463
[TBL] [Abstract][Full Text] [Related]
15. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
von Appen K; Klinkmann H
Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
[No Abstract] [Full Text] [Related]
16. Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
Desai JD; Shah BV
J Assoc Physicians India; 1991 Jun; 39(6):483-5. PubMed ID: 1938855
[No Abstract] [Full Text] [Related]
17. [Chronic kidney failure, anemia and erythropoietin].
Sulková S
Cas Lek Cesk; 1990 May; 129(18):545-9. PubMed ID: 2350772
[TBL] [Abstract][Full Text] [Related]
18. [Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma].
Valladares Ayerbes MJ; Valenzuela Claros JC; Reina Zoilo JJ; Ruiz Borrego M; Moreno Nogueira JA
An Med Interna; 1997 Nov; 14(11):593-4. PubMed ID: 9445590
[No Abstract] [Full Text] [Related]
19. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
Romero González R; Torquet Escuder P
Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
[No Abstract] [Full Text] [Related]
20. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
